My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 342

    1.

    Circulating adiponectin levels are reduced in nonobese but insulin-resistant first-degree relatives of type 2 diabetic patients.

    Pellmé F, Smith U, Funahashi T, Matsuzawa Y, Brekke H, Wiklund O, Taskinen MR, Jansson PA.

    Diabetes. 2003 May;52(5):1182-6.PMID: 12716750 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Inflammation, insulin resistance, and adiposity: a study of first-degree relatives of type 2 diabetic subjects.

    Kriketos AD, Greenfield JR, Peake PW, Furler SM, Denyer GS, Charlesworth JA, Campbell LV.

    Diabetes Care. 2004 Aug;27(8):2033-40.PMID: 15277436 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    4.

    Adiponectin expression in adipose tissue is reduced in first-degree relatives of type 2 diabetic patients.

    Lihn AS, Østergard T, Nyholm B, Pedersen SB, Richelsen B, Schmitz O.

    Am J Physiol Endocrinol Metab. 2003 Feb;284(2):E443-8. Epub 2002 Oct 8.PMID: 12388136 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults.

    Im JA, Kim SH, Lee JW, Shim JY, Lee HR, Lee DC.

    Metabolism. 2006 Nov;55(11):1546-50.PMID: 17046559 [PubMed - indexed for MEDLINE]Related articles

    6.

    Plasminogen activator inhibitor (PAI-1) activity is elevated in Asian and Caucasian subjects with non-insulin-dependent (type 2) diabetes but not in those with impaired glucose tolerance (IGT) or non-diabetic Asians.

    Nagi DK, Mohamed Ali V, Jain SK, Walji S, Yudkin JS.

    Diabet Med. 1996 Jan;13(1):59-64.PMID: 8741814 [PubMed - indexed for MEDLINE]Related articles

    7.

    Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.

    Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.

    J Clin Endocrinol Metab. 2003 Aug;88(8):3626-31.PMID: 12915646 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

    Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

    Metabolism. 2005 Apr;54(4):476-81.PMID: 15798954 [PubMed - indexed for MEDLINE]Related articles

    9.

    Plasma adiponectin and insulin resistance in Korean type 2 diabetes mellitus.

    Kim MJ, Yoo KH, Park HS, Chung SM, Jin CJ, Lee Y, Shin YG, Chung CH.

    Yonsei Med J. 2005 Feb 28;46(1):42-50.PMID: 15744804 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Hyperglycaemic siblings of Type II (non-insulin-dependent) diabetic patients have increased PAI-1, central obesity and insulin resistance compared with their paired normoglycaemic sibling.

    Herlihy OM, Barrow BA, Grant PJ, Levy JC.

    Diabetologia. 2002 May;45(5):635-41. Epub 2002 Apr 26.PMID: 12107743 [PubMed - indexed for MEDLINE]Related articles

    11.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.

    Gürlek A, Bayraktar M, Kirazli S.

    Diabetes Care. 2000 Jan;23(1):88-92.PMID: 10857975 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.

    Kruszynska YT, Yu JG, Olefsky JM, Sobel BE.

    Diabetes. 2000 Apr;49(4):633-9.PMID: 10871202 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients.

    Bajaj M, Suraamornkul S, Piper P, Hardies LJ, Glass L, Cersosimo E, Pratipanawatr T, Miyazaki Y, DeFronzo RA.

    J Clin Endocrinol Metab. 2004 Jan;89(1):200-6.PMID: 14715850 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

    Hanley AJ, Connelly PW, Harris SB, Zinman B.

    Diabetes Care. 2003 Dec;26(12):3219-25.PMID: 14633805 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

    Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA.

    J Clin Endocrinol Metab. 2001 May;86(5):1930-5.PMID: 11344187 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study.

    Festa A, D'Agostino R Jr, Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study.

    Diabetes. 2002 Apr;51(4):1131-7.PMID: 11916936 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Eur J Endocrinol. 2004 May;150(5):715-8.PMID: 15132729 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Serum CRP levels are equally elevated in newly diagnosed type 2 diabetes and impaired glucose tolerance and related to adiponectin levels and insulin sensitivity.

    Yuan G, Zhou L, Tang J, Yang Y, Gu W, Li F, Hong J, Gu Y, Li X, Ning G, Chen M.

    Diabetes Res Clin Pract. 2006 Jun;72(3):244-50. Epub 2005 Dec 27.PMID: 16377022 [PubMed - indexed for MEDLINE]Related articles

    20.

    Evidence of increased visceral obesity and reduced physical fitness in healthy insulin-resistant first-degree relatives of type 2 diabetic patients.

    Nyholm B, Nielsen MF, Kristensen K, Nielsen S, Østergård T, Pedersen SB, Christiansen T, Richelsen B, Jensen MD, Schmitz O.

    Eur J Endocrinol. 2004 Feb;150(2):207-14.PMID: 14763919 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity